药明康德

- 603259

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
药明康德(603259) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入3,285,671.652,079,928.19965,459.533,924,143.142,770,200.23
营业收入3,285,671.652,079,928.19965,459.533,924,143.142,770,200.23
二、营业总成本2,125,626.771,401,455.63671,212.902,734,226.821,996,716.40
营业成本1,753,809.861,155,412.42557,452.922,296,451.551,644,025.61
营业税金及附加27,396.5217,001.758,473.6930,118.1021,878.42
销售费用56,937.4639,436.7319,405.1974,538.8454,658.23
管理费用185,852.67117,541.6456,279.43287,934.20186,946.81
财务费用19,065.2120,620.387,160.84-78,668.36-6,196.96
研发费用82,565.0551,442.7122,440.84123,852.5095,404.28
资产减值损失----------
公允价值变动收益-3,443.59-18,218.30-4,593.8618,695.7621,764.65
投资收益409,853.99366,921.30153,765.3160,416.24-16,480.96
其中:对联营企业和合营企业的投资收益44,068.5824,026.876,400.2824,506.4719,895.02
汇兑收益----------
三、营业利润1,506,606.18993,111.84429,274.881,158,017.47789,086.93
加:营业外收入1,255.12769.3015.282,225.48558.69
减:营业外支出4,154.463,139.481,300.806,261.784,216.01
其中:非流动资产处置损失----------
四、利润总额1,503,706.84990,741.66427,989.361,153,981.16785,429.61
减:所得税费用283,087.49124,706.8456,442.47197,207.21125,268.46
五、净利润1,220,619.35866,034.81371,546.88956,773.95660,161.15
归属于母公司所有者的净利润1,207,551.30856,088.26367,196.10945,030.84653,293.47
少数股东损益13,068.059,946.554,350.7911,743.116,867.68
六、每股收益
基本每股收益(元/股)4.25003.01001.29003.28002.2500
稀释每股收益(元/股)4.21002.99001.28003.26002.2400
七、其他综合收益-9,595.32-3,788.5711,847.3418,571.89-335.38
八、综合收益总额1,211,024.03862,246.24383,394.23975,345.84659,825.77
归属于母公司所有者的综合收益总额1,199,070.62852,877.86379,206.41963,889.15652,977.80
归属于少数股东的综合收益总额11,953.419,368.384,187.8211,456.696,847.97
下载全部历史数据到excel中 返回页顶